{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:38:18Z","timestamp":1719952698005},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ejphar.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T11:52:57Z","timestamp":1395402777000},"page":"60-67","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells"],"prefix":"10.1016","volume":"732","author":[{"given":"Carolyn M.","family":"Summers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Hammons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasbir","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine","family":"Jochems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.03.004_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2005.12.018","article-title":"Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells","volume":"189","author":"Brown","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2014.03.004_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.03.004_bib3","first-page":"S9","article-title":"Clinical trials to establish methotrexate as a therapy for rheumatoid arthritis","volume":"28","author":"Coury","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ejphar.2014.03.004_bib4","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent cell line expressing human factor VIII-related antigen established by hybridization","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.03.004_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clim.2009.06.008","article-title":"Folate\/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels of monocyte chemoattractant protein-1","volume":"133","author":"Hammons","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2014.03.004_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/qjmed\/89.8.571","article-title":"The common \u201cthermolabile\u201d variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia","volume":"89","author":"Harmon","year":"1996","journal-title":"Quart. J. Med."},{"key":"10.1016\/j.ejphar.2014.03.004_bib7","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/rcm.3624","article-title":"Quantification of key red blood cell folates from subjects with defined MTHFR 677C>T genotypes using stable isotope dilution liquid chromatography\/mass spectrometry","volume":"22","author":"Huang","year":"2008","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"10.1016\/j.ejphar.2014.03.004_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","article-title":"Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations","volume":"93","author":"Jacques","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.03.004_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/07357909109032800","article-title":"Methotrexate and childhood leukemia","volume":"9","author":"Jonsson","year":"1991","journal-title":"Cancer Invest."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2014.03.004_bib10","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1007\/PL00014294","article-title":"The redox status of aminothiols as a clue to homocysteine-induced vascular damage?","volume":"157","author":"Koch","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ejphar.2014.03.004_bib11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/art.20278","article-title":"Toward a better understanding of methotrexate","volume":"50","author":"Kremer","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2014.03.004_bib12","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(00)02222-4","article-title":"Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity","volume":"355","author":"Landewe","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.03.004_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/ard.53.7.475","article-title":"Intra-individual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis","volume":"53","author":"Lebbe","year":"1994","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2014.03.004_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2008.12.008","article-title":"The up-regulation of monocyte chemoattractant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under long-term low folate stress is mediated by the p38 MAPK pathway","volume":"205","author":"Lu","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2014.03.004_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/mgme.2000.3027","article-title":"Folic acid: nutritional biochemistry, molecular biology, and role in disease processes","volume":"71","author":"Lucock","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejphar.2014.03.004_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.mco.0000247468.18790.1e","article-title":"Synergy of genes and nutrients: the case of homocysteine","volume":"9","author":"Lucock","year":"2006","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ejphar.2014.03.004_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2014.03.004_bib19","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(04)17445-X","article-title":"Spina Bifida","volume":"364","author":"Mitchell","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.03.004_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinbiochem.2009.04.014","article-title":"Folate and homocysteine phenotypes: comparative findings using research and clinical laboratory data","volume":"42","author":"Mitchell","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2014.03.004_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.1780281003","article-title":"Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis","volume":"28","author":"Moxley","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2014.03.004_bib22","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2014.03.004_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.autrev.2009.02.015","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"8","author":"Nurmohamed","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2014.03.004_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2014.03.004_bib25","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.03.004_bib26","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1002\/clc.4960141302","article-title":"The pathogenesis of atherosclerosis: an overview","volume":"14","author":"Schwartz","year":"1991","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ejphar.2014.03.004_bib27","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2014.03.004_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/153537020122600402","article-title":"Folate, homocysteine and neural tube defects: an overview","volume":"226","author":"Weinstein","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2014.03.004_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780280702","article-title":"Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial","volume":"28","author":"Williams","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2014.03.004_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/CS20030262","article-title":"Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells","volume":"106","author":"Yamauchi","year":"2004","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2014.03.004_bib31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0091-6749(99)70445-8","article-title":"Elevated levels of IL-8 in interstitial pneumonia induced by low-dose methotrexate","volume":"103","author":"Yoshida","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2014.03.004_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.0000087642.01082.E4","article-title":"Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes","volume":"93","author":"Zeng","year":"2003","journal-title":"Circ. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:35:24Z","timestamp":1565292924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"alternative-id":["S001429991400185X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.03.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}